[
    [
        {
            "time": "",
            "orginal_text": "294家医药公司分红582亿！恒瑞攒钱研发，迈瑞慷慨，云南白药分近50亿，Biotech几乎不分！",
            "features": {
                "keywords": [
                    "医药公司",
                    "分红",
                    "恒瑞",
                    "研发",
                    "迈瑞",
                    "云南白药",
                    "Biotech"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "294家医药公司分红582亿！恒瑞攒钱研发，迈瑞慷慨，云南白药分近50亿，Biotech几乎不分！",
            "scores": {
                "News_content": "294家医药公司分红582亿！恒瑞攒钱研发，迈瑞慷慨，云南白药分近50亿，Biotech几乎不分！",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "渝股点金 | 华龙证券罗涛：可关注智飞生物的交易性机会！",
            "features": {
                "keywords": [
                    "渝股",
                    "华龙证券",
                    "罗涛",
                    "智飞生物",
                    "交易性机会"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "渝股点金 | 华龙证券罗涛：可关注智飞生物的交易性机会！",
            "scores": {
                "News_content": "渝股点金 | 华龙证券罗涛：可关注智飞生物的交易性机会！",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "医药生物行业2021年中期投资策略报告：拥抱新兴产业方向 把握价值低估标的",
            "features": {
                "keywords": [
                    "医药生物",
                    "投资策略",
                    "新兴产业",
                    "价值低估"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药生物行业2021年中期投资策略报告：拥抱新兴产业方向 把握价值低估标的",
            "scores": {
                "News_content": "医药生物行业2021年中期投资策略报告：拥抱新兴产业方向 把握价值低估标的",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "orginal_text": "基金经理“半年考”临近，业绩冰火两重天",
            "features": {
                "keywords": [
                    "基金经理",
                    "半年考",
                    "业绩",
                    "冰火两重天"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "基金经理“半年考”临近，业绩冰火两重天",
            "scores": {
                "News_content": "基金经理“半年考”临近，业绩冰火两重天",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]